ALSTON & BIRD LLP for NOVO NORDISK INC.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report | Jan 22, 2019 | $60,000 | Replaced |
| 4th Quarter - Amendment (this page) | Nov 8, 2019 | $60,000 | Yes |
What was lobbied
9 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Implementation of Pub. L. 115-97 (H.R. 1, Tax Cuts and Jobs Act).
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARK RAYDER | — |
| CAROLYN E SMITH | — |
Health Issues HCR
General diabetes prevention; medication affordability and access; H.R. 4978/S. 2410, Chronic Disease Management Act of 2018; National Obesity Care Week.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHANIE CURTIS | — |
| PETER J ECKRICH | — |
| JOYCE E GRESKO | — |
| EARL POMEROY | — |
| MARK RAYDER | — |
| ROBERT SIGGINS | — |
| MARILYN K YAGER | — |
Trade (domestic/foreign) TRD
2018 Congressional trade agenda generally.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARK RAYDER | — |
Defense DEF
TRICARE pharmacy benefit in P.L. 115-232, the John S. McCain National Defense Authorization Act for Fiscal Year 2019.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHANIE CURTIS | — |
| MARK RAYDER | — |
Veterans VET
Insulin pen access.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHANIE CURTIS | — |
| MARK RAYDER | — |
Foreign Relations FOR
Issues related to inbound investment in H.R. 4311/S. 2098 Foreign Investment Risk Review Modernization Act of 2017 (CFIUS Reform).
| Lobbyist | Covered position, as disclosed |
|---|---|
| PETER J ECKRICH | — |
| MARK RAYDER | — |
Medicare/Medicaid MMM
Medicare Diabetes Prevention Program; diabetes self-management education; H.R. 3124/S. 1299/Preventing Diabetes in Medicare Act; H.R. 1953/S. 830 Treat and Reduce Obesity Act; Issues related to Medicare Part D included in Section 53116 of H.R. 1892 (Pub. L. 115-123), Bipartisan Budget Act and H.R. 1625 (Pub. L. 115-141), Consolidated Appropriations Act; H.R. 849/S. 260 including coverage gap ("donut hole") access and averting catastrophic coverage Out of Pocket (OOP) "cliff"; Protecting Seniors' Access to Medicare Act of 2017 and S. 251 Protecting Medicare from Executive Action Act of 2017 (IPAB Repeal); H.R. 3921 HEALTHY KIDS Act (CHIP Reauthorization).
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHANIE CURTIS | — |
| PETER J ECKRICH | — |
| JOYCE E GRESKO | — |
| EARL POMEROY | — |
| MARK RAYDER | — |
| ROBERT SIGGINS | — |
| MARILYN K YAGER | — |
Budget/Appropriations BUD
H.R. 2953/S. 2164, Preventive Health Savings Act (CBO scoring of preventive health); National Diabetes Prevention Program and other CDC diabetes prevention activities in P.L. 115-96 (CR of FY18 Labor, Health and Human Services, and Education Appropriations), and FY19 Labor, Health and Human Services, and Education Appropriations.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHANIE CURTIS | — |
| PETER J ECKRICH | — |
| JOYCE E GRESKO | — |
| EARL POMEROY | — |
| MARK RAYDER | — |
| ROBERT SIGGINS | — |
| MARILYN K YAGER | — |
Pharmacy PHA
Issues related to P.L. 115-52 (H.R. 2430/S. 934) FDA Reauthorization Act of 2017 (Prescription Drug User Fee Act VI); H.R. 1245/S. 469 Affordable and Safe Prescription Drug Importation Act; H.R. 1776/S. 771 Improving Access to Affordable Prescription Drugs Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHANIE CURTIS | — |
| MARK RAYDER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.